An Observational Study of Circulating Plasma and Serum Insulin-Like Growth Factor 1 as Prognostic Biomarkers in Surgical Hepatocellular Carcinoma Patients
An Observational Study of Circulating Plasma and Serum Insulin-Like Growth Factor 1 as Prognostic Biomarkers in Surgical Hepatocellular Carcinoma Patients
An Observational Study of Circulating Plasma and Serum Insulin-Like Growth Factor 1 as Prognostic Biomarkers in Surgical Hepatocellular Carcinoma Patients

An Observational Study of Circulating Plasma and Serum Insulin-Like Growth Factor 1 as Prognostic Biomarkers in Surgical Hepatocellular Carcinoma Patients

Compartilhe

Publicado por: - Oncologista - CRM 170.446
O Dr. Roberto Pestana (CRM 170.446) é oncologista clínica do centro de oncologia do Hospital Israelita Albert Einstein. Além disso, ele é médico do ambulatório de sarcomas do Hospital Municipal Vila Santa Catarina.

VER TODAS AS PUBLICAÇÕES